InvestorsHub Logo
icon url

McMagyar

12/28/22 10:31 AM

#394933 RE: BAR123 #394923

A transition strategy to a Big Pharma..
Reasonable..

That could be another
positive after peer reviewed
And revenue
icon url

attilathehunt

12/28/22 1:45 PM

#395016 RE: BAR123 #394923

I rather see TGD as a COO and bring on a new CEO (WS savvy and articulate)
icon url

DoTheRightThing

12/28/22 2:04 PM

#395024 RE: BAR123 #394923

At the very least we could have someone else in charge of communications, presentations, etc. Every time Missling speaks we hundreds of millions in market cap. Ideally he wouldn't be involved with the trials either giving all his mishandlings but at least that would be a start.
icon url

Hoskuld

12/28/22 2:36 PM

#395034 RE: BAR123 #394923

A new CEO is not needed - drug approvals are needed. When those happen then suddenly Dr, Missling will seem like a genius to all of those who are now panning him.